We are live on ! Find out more
DNA.WS

Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS

Delisted

DNA.WS was delisted on the 3rd of September, 2024.

Back to rankings

3 hedge funds and large institutions have $3.66K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $3.91K → $3.66K (-$250)

40% less funds holding

Funds holding: 5 → 3 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SBLIC
Security Benefit Life Insurance Company
Kansas
-$291
2
SPIA
Steward Partners Investment Advisory
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
AS
1
Altshuler Shaham
Israel
$3.66K – – –
HIA
2
Harbor Investment Advisory
Maryland
$1 – – –
NC
3
NewSquare Capital
Pennsylvania
$1 – – –
SBLIC
4
Security Benefit Life Insurance Company
Kansas
– -$291 -64,709 Closed
SPIA
5
Steward Partners Investment Advisory
New York
– -$1 -200 Closed

DNA.WS Hedge Fund Activity: Q4 2024 in Review

3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) for Q4 2024, worth a combined $3.66K — down 6.4% from $3.91K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DNA.WS and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Security Benefit Life Insurance Company, exiting entirely with an estimated $291 sold.

  • 3 institutional investors held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) as of Q4 2024, down from 5 in Q3 2024.
  • Funds reported $3.66K of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share stock for Q4 2024, down 6.4% quarter-over-quarter.
  • 0 funds opened new Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share positions in Q4 2024 and 2 closed out, a net change of -2 holders.
  • The largest Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share seller in Q4 2024 was Security Benefit Life Insurance Company, an estimated $291 sold.

Based on aggregated 13F filings for Q4 2024.